Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.
Contractor H, Støttrup NB, Cunnington C, Manlhiot C, Diesch J, Ormerod JO, Jensen R, Bøtker HE, Redington A, Schmidt MR, Ashrafian H, Kharbanda RK.
Contractor H, et al.
Basic Res Cardiol. 2013 May;108(3):343. doi: 10.1007/s00395-013-0343-3. Epub 2013 Mar 24.
Basic Res Cardiol. 2013.
PMID: 23525499
Clinical Trial.
However, rIPC protection was lost after pre-treatment with the ALDH-2 inhibitor cyanamide (62 7.6 % controls, n = 10, versus 61 6.9 % rIPC after cyanamide, n = 10, P > 0.05). ...
However, rIPC protection was lost after pre-treatment with the ALDH-2 inhibitor cyanamide (62 7.6 % controls, n = 10, versus 61 6.9 % …